title: Where and when device therapy may be useful in the management of drug-resistant hypertension.
abstract: Device therapy for the treatment of uncontrolled and resistant hypertension has evolved significantly over the past several decades. Both renal artery disease and sympathetic hyperactivity have been linked to resistant hypertension. This manuscript will review the current evidence base supporting device therapy (e.g., renal artery revascularization, sympathetic nervous system modulation) for resistant hypertension.
authors.affiliation: Michigan Heart, 5325 Elliott Dr., Ste. #202, Ypsilanti, MI, 48197, USA, HAronow@MichiganHeart.com.
authors.forename: Herbert D
authors.initials: HD
authors.lastname: Aronow
authors.forename: Jun
authors.initials: J
authors.lastname: Li
authors.forename: Sahil A
authors.initials: SA
authors.lastname: Parikh
mesh_terms: D017115:Catheter Ablation; D019317:Evidence-Based Medicine; D006801:Humans; D006973:Hypertension / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D017410:Practice Guidelines as Topic; D012077:Renal Artery / Q000294:innervation* / Q000503:physiopathology; D051436:Renal Insufficiency, Chronic / Q000150:complications / Q000503:physiopathology / Q000628:therapy*; D012307:Risk Factors; D015607:Stents; D013562:Sympathectomy; D013564:Sympathetic Nervous System / Q000503:physiopathology*; D016896:Treatment Outcome